糖尿病
血脂异常
益生菌
医学
氧化应激
免疫系统
2型糖尿病
肠道菌群
肥胖
生物信息学
免疫学
生物
内科学
内分泌学
细菌
遗传学
作者
Shiming Li,Zichao Liu,Qi Zhang,Dan Su,Pengjie Wang,Yixuan Li,Wenbiao Shi,Qian Zhang
出处
期刊:Nutrients
[Multidisciplinary Digital Publishing Institute]
日期:2024-07-31
卷期号:16 (15): 2494-2494
被引量:30
摘要
Diabetes has become one of the most prevalent global epidemics, significantly impacting both the economy and the health of individuals. Diabetes is associated with numerous complications, such as obesity; hyperglycemia; hypercholesterolemia; dyslipidemia; metabolic endotoxemia; intestinal barrier damage; insulin-secretion defects; increased oxidative stress; and low-grade, systemic, and chronic inflammation. Diabetes cannot be completely cured; therefore, current research has focused on developing various methods to control diabetes. A promising strategy is the use of probiotics for diabetes intervention. Probiotics are a class of live, non-toxic microorganisms that can colonize the human intestine and help improve the balance of intestinal microbiota. In this review, we summarize the current clinical studies on using probiotics to control diabetes in humans, along with mechanistic studies conducted in animal models. The primary mechanism by which probiotics regulate diabetes is improved intestinal barrier integrity, alleviated oxidative stress, enhanced immune response, increased short-chain fatty acid production, etc. Therefore, probiotic supplementation holds great potential for the prevention and management of diabetes.
科研通智能强力驱动
Strongly Powered by AbleSci AI